| 标题 |
[求助补充材料]
Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 tria |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:HARPREET SINGH BAJAJ; Michelle Welch; Parag Shah; Eduardo Luna; Fatima-Zahra Jaouimaa; et al 出版日期:2026-06-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)